Kestra Medical Technologies, Ltd Common Stock

Quarterly Financials

Values in thousands 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Revenue
$19,371
$17,233
$15,090
$14,710
Gross Profit
8,851
7,633
6,547
5,830
EBITDA
-28,878
-47,413
-18,070
EBIT
-49,249
-19,958
Net Income
-25,826
-52,053
-21,509
-20,368
Net Change In Cash
19,371
17,233
15,090
14,710
Free Cash Flow
-34,440
-31,743
-22,447
-22,453
Cash
201,214
237,595
54,352
76,918
Basic Shares
51,304
49,533
49,533
49,533

Annual Financials

Values in thousands 2025-04-30 2024-04-30 2023-04-30 2021-04-30
Revenue
$59,815
$27,814
$7,630
$0
Gross Profit
24,210
362
-10,651
EBITDA
-97,977
-76,306
-73,739
-32,326
EBIT
-105,945
-87,866
-78,594
-32,746
Net Income
-113,814
-94,120
-84,238
-34,101
Net Change In Cash
59,815
27,814
7,630
0
Free Cash Flow
-101,199
-84,749
-85,103
-30,231
Cash
237,595
8,249
14,810
24,342
Basic Shares
49,533
49,533
49,533
49,533

Earnings Calls

Quarter EPS
2025-07-31
-$0.50
2025-04-30
-$1.05
2025-01-31
-$1.18